epigallocatechin gallate has been researched along with vitamin k 3 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Andrieu, V; Brunel, JM; Douafer, H; Phanstiel, O | 1 |
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Baran, I; Barresi, V; Cirrone, GA; Condorelli, DF; Cuttone, G; Ganea, C; Garaiman, A; Grasso, R; Gulino, M; Mocanu, MM; Musso, N; Musumeci, F; Privitera, S; Scordino, A; Ursu, I | 1 |
| Baran, I; Dimancea, A; Filippi, A; Gaman, MA; Ganea, C; Garaiman, A; Goicea, A; Ionescu, D; Tofolean, IT | 1 |
1 review(s) available for epigallocatechin gallate and vitamin k 3
| Article | Year |
|---|---|
Antibiotic Adjuvants: Make Antibiotics Great Again!
Topics: Adjuvants, Pharmaceutic; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacteria; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cell Wall; Drug Resistance, Multiple, Bacterial | 2019 |
5 other study(ies) available for epigallocatechin gallate and vitamin k 3
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoids.
Topics: Apoptosis; Catechin; Cell Cycle; Cell Survival; Clone Cells; Flavonoids; Humans; Hydrogen Peroxide; Jurkat Cells; Kinetics; Leukemia; Luminescence; NADP; Oxidants; Protons; Quantum Theory; Quercetin; Time Factors; Vitamin K 3 | 2012 |
Cellular determinants involving mitochondrial dysfunction, oxidative stress and apoptosis correlate with the synergic cytotoxicity of epigallocatechin-3-gallate and menadione in human leukemia Jurkat T cells.
Topics: Apoptosis; Calcium; Catechin; Cell Survival; Humans; Jurkat Cells; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Vitamin K 3 | 2016 |